A new study published in JAMA reveals that despite eligibility, lung cancer screening (LCS) is dramatically underutilized compared to breast (BCS) and colorectal cancer screening (CCS). Among dual-eligible individuals, only about 17% underwent LCS, while more than 64% completed BCS or CCS.
Keep Reading
Add A Comment